Chemokines as Potential Therapeutic Targets in Atherosclerosis
Journal:
Current Drug Targets
Volume:
7
Page:
13-27
Author(s):
Y. A. Sheikine and G. K. Hansson
Pharmacotherapy of Schizophrenia: The Past, Present and Future
Journal:
Current Drug Therapy
Volume:
1
Page:
1-7
Author(s):
Shahin Akhondzadeh
Cerebral White Matter Lesions, Risk of Stroke and Cerebrovascular Protection with Angiotensin Receptor Blockers
Journal:
Current Drug Therapy
Volume:
1
Page:
9-16
Author(s):
Alejandro d. l. Sierra and Cristina Sierra
Pharmacological Support of Neurorehabilitation
Journal:
Current Drug Therapy
Volume:
1
Page:
17-22
Author(s):
Burkhard Pleger and Patrick Ragert
Role of Angiotensin-1-Receptor Blockers In Cardiorenal Disease
Journal:
Current Drug Therapy
Volume:
1
Page:
47-54
Author(s):
Rene R. Wenzel
Enantiomeric Local Anesthetics: Can Ropivacaine and Levobupivacaine Improve Our Practice?
Journal:
Current Drug Therapy
Volume:
1
Page:
85-89
Author(s):
Andrea Casati and Marco Baciarello
Cardiotoxicity of 5-Fluorouracil
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
4
Page:
1-5
Author(s):
P. Alter, M. Herzum, M. Soufi, J. R. Schaefer and B. Maisch
Pharmacogenomics of Essential Hypertension: Are We Going the Right Way?
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
4
Page:
7-15
Author(s):
F. Filigheddu, C. Troffa and N. Glorioso
Imidazoline Receptors, Novel Agents and Therapeutic Potential
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
4
Page:
17-32
Author(s):
G. A. Head and D. N. Mayorov
Treatment of Acute Leukaemias with Monoclonal Antibodies: Current Status and Future Prospects
Journal:
Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume:
4
Page:
33-52
Author(s):
G. Leone, S. Sica, M. T. Voso, S. Rutella and L. Pagano